Orthobiologics’ company Cerapedics, based in Westminster, Colo., entered into a purchasing agreement with Charlotte, N.C.-based healthcare alliance Premier. The agreement covers Cerapedics’ i-FACTOR Peptide Enhanced Bone Graft. Premier members will have access to i-FACTOR special pricing and pre-negotiated terms.
Headquartered in Melsungen, Germany, B. Braun Medical joined forces with Israel-based Trendlines Group on an investment in ApiFix, a Trendlines portfolio company. B. Braun took on a lead position in ApiFix’s B round financing, with the company’s Aesculap division investing $2.8 million in the $5 million round. The financing round is projected to close by the end of 2016.
More articles on devices:
Global biological implant market to total $9.8B by 2024 — 5 notes
ISASS issues policy statement recommending coverage of decompression with interlaminar stabilization: 5 insights
Brazilian surgeons utilize Microsoft’s HoloLens for spinal fusions: 5 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
